Laiho E, Ignatius J, Mikkola H, Yee V C, Teller D C, Niemi K M, Saarialho-Kere U, Kere J, Palotie A
Department of Clinical Chemistry, University of Helsinki, Finland.
Am J Hum Genet. 1997 Sep;61(3):529-38. doi: 10.1086/515498.
Autosomal recessive congenital ichthyosis (ARCI) is a rare, heterogenous keratinization disorder of the skin, classically divided into two clinical subtypes, lamellar ichthyosis (LI) and nonbullous congenital ichthyosiformis erythroderma (CIE). Recently, strong evidence for the involvement of the transglutaminase 1 gene (TGM1) in LI has evolved. We have studied ARCI in the isolated Finnish population, in which recessive disorders are often caused by single mutations enriched by a founder effect. Surprisingly, five different mutations of TGM1 (Arg141His, Arg142Cys, Gly217Ser, Val378Leu, and Arg395Leu) were found in Finnish ARCI patients. In addition to affected LI patients, we also identified TGM1 mutations in CIE patients. Moreover, haplotype analysis of the chromosomes carrying the most common mutation, a C-->T transition changing Arg142 to Cys, revealed that the same mutation has been introduced twice in the Finnish population. In addition to this Arg142Cys mutation, three other mutations, in Arg141 and Arg142, have been described elsewhere, in other populations. These findings suggest that this region of TGM1 is more susceptible to mutation. The corresponding amino acid sequence is conserved in other transglutaminases, but, for example, coagulation factor XIII (FXIII) mutations do not cluster in this region. Protein modeling of the Arg142Cys mutation suggested disruption or destabilization of the protein. In transfection studies, the closely related transglutaminase FXIII protein with the corresponding mutation was shown to be susceptible to degradation in COS cells, further supporting evidence of the destabilizing effect of the Arg142Cys mutation in TGM1.
常染色体隐性先天性鱼鳞病(ARCI)是一种罕见的、异质性的皮肤角化障碍,传统上分为两种临床亚型,即板层状鱼鳞病(LI)和非大疱性先天性鱼鳞病样红皮病(CIE)。最近,有确凿证据表明转谷氨酰胺酶1基因(TGM1)与LI的发病机制有关。我们对芬兰孤立人群中的ARCI进行了研究,在该人群中,隐性疾病通常由奠基者效应富集的单一突变引起。令人惊讶的是,在芬兰ARCI患者中发现了TGM1的五种不同突变(Arg141His、Arg142Cys、Gly217Ser、Val378Leu和Arg395Leu)。除了受影响的LI患者外,我们还在CIE患者中鉴定出了TGM1突变。此外,对携带最常见突变(C→T转换,将Arg142变为Cys)的染色体进行单倍型分析发现,相同的突变在芬兰人群中出现了两次。除了这种Arg142Cys突变外,其他人群中还描述了Arg141和Arg142的另外三种突变。这些发现表明TGM1的这一区域更容易发生突变。相应的氨基酸序列在其他转谷氨酰胺酶中是保守的,但是,例如,凝血因子XIII(FXIII)的突变并不集中在这一区域。Arg142Cys突变的蛋白质建模表明该蛋白质结构被破坏或不稳定。在转染研究中,具有相应突变的密切相关的转谷氨酰胺酶FXIII蛋白在COS细胞中易被降解,这进一步支持了Arg142Cys突变对TGM1有不稳定作用的证据。